Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Veeva SystemsVEEV +2.01%88 EV-to-EBITDA is 28.30 as of Aug. 06, 2026, which is 53% below its 10-year median of 59.67. GuruFocus rates VEEV with a GF Score™ of 88/100 and a GF Value™ of $290.82 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 510 Healthcare Providers & Services companies, Veeva Systems ranks worse than 84.12% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Veeva Systems's enterprise value is $28,170 Mil.
Veeva Systems's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 was $995 Mil. Therefore, Veeva Systems's EV-to-EBITDA for today is 28.30.
The historical rank and industry rank for Veeva Systems's EV-to-EBITDA or its related term are showing as below:
VEEV'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 18.32 Med: 59.67 Max: 160.8
Current: 28.3
During the past 13 years, the highest EV-to-EBITDA of Veeva Systems was 160.80. The lowest was 18.32. And the median was 59.67.
VEEV's EV-to-EBITDA is ranked worse than 84.12% of 510
companies
in the Healthcare Providers & Services industry
Industry Median: 11.07
vs VEEV: 28.30
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Veeva Systems (NYSE:VEEV) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Veeva Systems's PE Ratio (TTM) for today is calculated as:
Veeva Systems's share price for today is $217.80.
Veeva Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.610.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Veeva Systems's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Veeva Systems's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Veeva Systems's EV-to-EBITDA falls into.
Veeva Systems's current Enterprise Value is $28,170 Mil.
Veeva Systems's EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $995 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (VEEV) has a EV-to-EBITDA of 28.30 as of Aug. 06, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Veeva Systems. This is 53% below median its historical median of 59.67. Over the past decade, Veeva Systems' EV-to-EBITDA has ranged from 18.32 to 160.80. According to the industry distribution chart, Veeva Systems ranks #429 out of 510 companies in the Healthcare Providers & Services industry, placing it in the top 84.1%.
Is Veeva Systems' EV-to-EBITDA too high?
Veeva Systems' current EV-to-EBITDA of 28.30 is 53% below median its 10-year median of 59.67. Over the past 10 years, this metric has ranged from a low of 18.32 to a high of 160.80. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.07. Veeva Systems' value of 28.30 is 155.6% above this industry median. Based on the distribution chart, Veeva Systems ranks #429 out of 510 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Veeva Systems has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' EV-to-EBITDA compare to BTSG and HQY?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #429 out of 510 companies for EV-to-EBITDA. This places Veeva Systems in the lower half of its industry. The industry median EV-to-EBITDA is 11.07. Veeva Systems' value of 28.30 is 155.6% above this benchmark. Historically, Veeva Systems' own EV-to-EBITDA has ranged from 18.32 to 160.80 over the past decade. While the company's 10-year median is 59.67 vs. the industry median of 11.07, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.07, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current EV-to-EBITDA of 28.30 is 155.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Veeva Systems. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current EV-to-EBITDA is 28.30, which is 53% below median its own 10-year median of 59.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (VEEV) is currently considered Modestly Undervalued. The stock's GF Value™ is $290.82, compared to a current price of $217.80 — trading 25.1% below its estimated fair value. The current EV-to-EBITDA is 28.30, which is 53% below median its 10-year median of 59.67 and 155.6% above the Healthcare Providers & Services industry median of 11.07. Veeva Systems' overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Veeva Systems (VEEV), the current EV-to-EBITDA is 28.30 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $217.80 is trading 25.1% below its estimated GF Value™ of $290.82.
GuruFocus considers Veeva Systems to be Modestly Undervalued.
Key valuation signals for VEEV:
EV-to-EBITDA: 28.30 (53% below median its 10-year median of 59.67)
GF Value™: $290.82 vs. price of $217.80 (25.1% below fair value)
Industry Position: 155.6% above the Healthcare Providers & Services median (#429 of 510)
No single metric tells the full story. See the VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
88GF Score
Get the complete analysis for VEEV
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEEV has been successfully added to your 
